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UVA Radiation Induces Suppression of Perforin-Granule Release
from CD8hiþ Cytotoxic T Lymphocytes Ex Vivo
To the Editor:
Ultraviolet (UV) phototherapy is routinely employed in the
treatment of several dermatological and some other
diseases. In addition to the beneficial UV effects, there is
a close relationship between the cumulative UV dose, aging
of the skin, and UV-induced skin tumors. The influence of
UV on the cytotoxic effector mechanisms in tumor defense
and immunoregulation is not very well understood. In
particular, UV effects upon the release of perforin from
CD8þ cytotoxic T lymphocytes (CTL) have not been
investigated so far. Following activation of CTL and natural
killer cells, the 70 kDa protein perforin is released from the
so-called lytic granules toward a target plasma membrane,
where it inserts and polymerizes to a pore of 16 nm
in diameter (Russell and Ley, 2002). Other lytic granule
components like granzyme B use these pores to enter the
target and to initiate apoptosis (Darmon et al, 1996).
Employing this mechanism CTL are crucially involved in
the regulation of immunoglobulin production, proliferation of
specific Tcells, and the TH1/TH2 balance (Hussell et al, 1997;
Kagi et al, 1999; Shustov et al, 2000). Moreover, perforin-
based cytotoxicity eliminates virus-infected cells, intra-
cellular bacteria, tumor cells, and is engaged in transplant
rejection processes (Kagi et al, 1994; Schulz et al, 1995;
Yasukawa et al, 1999; Street et al, 2001). This study was
designed to study the effect of UVB (280–320 nm) and UVA
(320–400 nm) in different doses on the release of perforin
granules from CD8hiþ CTL ex vivo.
Peripheral blood mononuclear cells (PBMC) from healthy
volunteers (six males, six females, age: 32  6 y) obtained
by Ficoll density gradient centrifugation were split at 6  105
cells per 75 cm2 cell culture dish and UV irradiated in 10 mL
PBS in a 30 1C waterbath. UVA source: a PUVA 800 lamp
(Waldmann, Schwenningen, Germany, Philips UVA 40W
Performance, 320–400 nm, emission peak 355 nm Philips,
Hamburg, Germany); UVB source: a UV-3000 K lamp
(Waldmann, Waldmann F85/100W/UV21, 280–340 nm,
emission peak 310 nm). The lamp output was monitored
with a Centra radiometer (Osram, Berlin, Germany) equip-
ped with UVB and UVA sensors and calibrated against a
Phillips lamp type 09 (UVA) and a Phillips lamp type 12
(UVB). Measurements were corrected for the lamps used by
factors provided by the manufacturer. The UV dose was
varied by adjusting the time of radiation. Following radia-
tion, cells were aliquoted and the perforin release assay was
performed as described in detail elsewhere (Ambach et al,
2001a, b, 2003; Weren et al, 2003). Briefly, cells were
incubated with or without ionomycin (1 mg per mL) and
PMA (50 ng per mL, both from Calbiochem, Darmstadt,
Germany) at 37 1C. Incubation was stopped after different
time intervals. Doublestaining was performed with mono-
clonal antibodies against perforin (FITC-labeled, clone dG9,
Ho¨lzel, Cologne, Germany and BD Biosciences, Heidelberg,
Germany) and CD8 (Phycoerythrin-labeled, clone UCHT4;
Ho¨lzel and Dianova, Hamburg, Germany) and analyzed by
flow immunocytometry. Lymphocytes expressing high
amounts of CD8 were considered to be CD8hiþ CTL.
Reduction of perforinþ CD8hiþ CTL over time was used as
a measure for the release of lytic granules. To compare
individual release kinetics, the portion of perforinþ CD8hiþ
CTL at time point 0 min was set to 100%:
Relative portion of perforinþ CTL ¼A ðXminÞ
A ð0minÞ
where A is the absolute portion of perforinþ CD8hiþ CTL
(%) as determined in the flow cytometer at time point.
Results are given as mean  standard deviation (SD). A
two-tailed t test assuming unequal variances was applied
for statistical analysis. The level of significance was set to
po 0.05. The study design received institutional approvals
and adhered to the Declaration of Helsinki.
Before PMA/ionomycin stimulation, 45%  10% of all
CD8hiþ CTL contained perforinþ granules (n¼13). After
PMA/ionomycin stimulation, 23%  8% and 12%  6% of
these cells stained positive for perforin at 60 and 120 min.
On average, 25% of initially perforinþ /CD8hiþ CTL relea-
sed their perforin granules completely within 37  14 min
(t(25% perforin release)). Following exposure of PBMC to
different doses of UVA (3–10 J per cm2) a substantial and
concentration-dependent inhibition of PMA/ionomycin-sti-
mulated perforin-granule release from CD8hiþ CTL was
observed (Fig 1A–C, Table 1). At 120 min after PMA/
ionomycin stimulation, significantly more CD8hiþ CTL
radiated with 5 or 10 J per cm2 UVA still contained perforin
(4.4  4.6- and 6.0  6.6-fold more, respectively; n¼6) as
compared with unirradiated CTL. The lowest UVA dose (3 J
per cm2) did not influence granule release at all (Fig 1A).
Radiation of CD8hiþ CTL with UVB (30–150 mJ per cm2) did
not influence significantly the amount and kinetics of the
PMA/ionomycin-stimulated perforin-granule release from
doses of 30 up to 150 mJ per cm2 at all time points
investigated (Fig 1D, Table 1). Even 300 mJ per cm2 UVB
had no inhibitory effect (data not shown).
Abbreviations: CTL, cytotoxic T lymphocytes; PMA, phorbol 12-
myristate 13 acetate; SD, standard deviation; UV, ultraviolet light
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This study demonstrates a concentration- and wave-
length-dependent UV interference with a central CTL
effector mechanism, specifically, an inhibition of the PMA/
ionomycin-stimulated release of perforin granules from
peripheral CD8hiþ CTL by UVA with a maximum effect at
10 J per cm2, but not UVB in doses up to 300 mJ per cm2.
These in vitro data may be of at least limited relevance in
vivo. Even considering the fact that a major part of UV light
will be reflected and/or absorbed by the skin, UV doses high
enough to exert the observed effect on CTL may be
experienced in vivo: during a sunny summer day, e.g. in the
Mediterranean between 10 a.m. and 4 p.m., levels of 150
J per cm2 UVA and 4 J per cm2 UVB may be reached.
Sunbathing using UVB protectors between 12 a.m. and
2 p.m. on a sunny summer day in Glasgow, UK, (McGinley
et al, 1998) or tanning for 8–10 min using a Phillips TL-10R
lamp (250 W per m2) results in consumption of 20 J per cm2
UVA. Recently, we demonstrated in patients with atopic
dermatitis (AD) a hyper-releasability of lytic granules from
CTL (Ambach et al, 2001a). Thus, the beneficial effects of
UVA phototherapy in AD patients might be attributed in
part to the suppression of the perforin hyper-releasability.
Noteworthy, UVA therapy is not effective at all in patients
with acute exacerbated psoriasis who show an increase of
perforinþ CD8þ CTL (Behrendt et al, 2000). Taken together,
our data demonstrate for the first time a significant
modulation of the T-cellular perforin system by UVA. These
effects may furthermore contribute to the known UV
suppression of antiviral and antitumor immunity and, there-
fore, to clinical manifestation of, e.g., herpes solaris or UV-
induced skin tumors. The data may confirm to some ex-
tent the rational for UVA treatment of CD8þ dominated
diseases.
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(n¼ 6; D) did not influence this process. Statistical significance was
calculated in relation to PMA/ionomycin-stimulated unirradiated cells
(po0.05, po 0.01, po0.001). Unirradiated, unstimulated con-
trol, ; PMA/ionomycin-stimulatory treatment, ; UV-radiated
samples, dotted lines.
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mononuclear cells; CTL, cytotoxic T lymphocytes.
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